Optomed Oyj reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was EUR 3.66 million compared to EUR 4.01 million a year ago. Net loss was EUR 1.53 million compared to EUR 1.4 million a year ago.

Basic loss per share from continuing operations was EUR 0.09 compared to EUR 0.1 a year ago.